BridgeMD
Compares treatment options for Vaping Cessation
Official title Nicotine Patch Plus Nicotine Mouth Spray Versus Nicotine Reduction for Vaping Cessation
ClinicalTrials.gov ID: NCT06832098
What this study is testing
What is Nicotine patches plus nicotine mouth spray?
Nicotine patches plus nicotine mouth spray is an investigational medicine, given as an once-weekly, being studied as a potential treatment for vaping cessation.
Also referred to as HABITROL patches, NICORETTE QUICKMIST.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This research focuses on maximizing the chances of successfully quitting vaping. A large, pragmatic community-based clinical trial is planned in New Zealand to build on existing evidence from previous vaping and smoking cessation research undertaken by the study team.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 and older. Healthy volunteers may be eligible.
You may be able to join if
- Live in New Zealand.
- Vape nicotine at least weekly (one or more days out of the past seven days).
- Used to smoke (i.e. they have smoked tobacco regularly but not at all in the past six months) or have never smoked (i.e., they have never been a...
- Are aged ≥16 years.
- Are motivated to quit vaping in the next eight weeks.
You likely can't join if
- They have another person in their household currently enrolled in the study.
- They smoke tobacco currently or were a recent regular user of tobacco.
- They are enrolled in another vaping cessation programme/trial.
- They self-report having had a serious cardiovascular event, or hospitalisation for a cardiovascular complaint, in the previous four weeks (e.g...
- They self-report uncontrolled hypertension.
- They have a strong preference to use/not use NRT or nicotine tapering.
See the full eligibility criteria
- Live in New Zealand.
- Vape nicotine at least weekly (one or more days out of the past seven days).
- Used to smoke (i.e. they have smoked tobacco regularly but not at all in the past six months) or have never smoked (i.e., they have never been a regular user of smoked tobacco, defined as less than 100 cigarettes in...
- Are aged ≥16 years.
- Are motivated to quit vaping in the next eight weeks.
- Are able to provide consent.
- Have access to the internet via a computer or smart phone.
- Are a registered patient at a New Zealand medical facility.
- They have another person in their household currently enrolled in the study.
- They smoke tobacco currently or were a recent regular user of tobacco.
- They are enrolled in another vaping cessation programme/trial.
- They self-report having had a serious cardiovascular event, or hospitalisation for a cardiovascular complaint, in the previous four weeks (e.g. stroke, myocardial infarction, unstable angina, cardiac arrhythmia...
- They self-report uncontrolled hypertension.
- They have a strong preference to use/not use NRT or nicotine tapering.
- They are current users of smoking cessation pharmacotherapy (e.g. NRT, varenicline, cytisine, nortriptyline [including if it is used for a different indication], and amitriptyline [as it converts to nortriptyline].
- They are currently enrolled in another vaping cessation programme/trial.
The study team makes the final eligibility decision.
Where it's taking place
- Auckland, New Zealand
Compensation & support
Some study costs may be covered.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Auckland, New Zealand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.